Tolosa Hunt syndrome

View Details
Status
Done

Diagnostic criteria

  • Unilateral orbital or periorbital headache fulfilling criterion C
  • Both of the following:
    • granulomatous inflammation of the cavernous sinus, superior orbital fissure or orbit, demonstrated by MRI or biopsy
    • paresis of one or more of the ipsilateral IIIrd, IVth and/or VIth cranial nerves
  • Evidence of causation demonstrated by both of the following:
    • headache is ipsilateral to the granulomatous inflammation
    • headache has preceded paresis of the IIIrd, IVth and/or VIth nerves by ≤2 weeks, or developed with it
  • Not better accounted for by another ICHD-3 diagnosis.

Numbers

  • Any age from the 1st to the 8th decades of life
  • No sex predilection.
  • Either side may be affected, with case reports of bilateral simultaneous involvement.

Clinical features

  • Painful ophthalmoplegia.
  • Pain
    • Defining symptom.
    • Lasts an average of 8 weeks if untreated.
    • Ocular motor cranial nerve palsies may coincide with the onset of pain or follow it within a period of up to 2 weeks.
      • It is usually described as “intense”, “severe”, “boring”, “lancinating”, or “stabbing”. It is periorbital in location, frequently extending into the retro-orbital, frontal, and temporal regions.
  • CN3-6 may be involved, in various combinations.
    • Pupillary reactions
      • most of the time is normal,
      • If abnormal can be either
        • parasympathetic (oculomotor nerve) dysfunction OR
        • sympathetic (third order neuron Horner's syndrome) dysfunction
  • If CN2 affected then orbital apex may be involved
  • Optic disc may be normal, swollen, or pale in appearance, and visual decline may be minimal or lead to blindness.
    • Loss of acuity is variable
  • Infrequently, other cranial nerves not located within the cavernous sinus/superior orbital fissure may be affected. These include the maxillary and mandibular branch of the trigeminal nerve, and the facial nerve.
  • There are no reports of systemic or other neurological involvement in Tolosa-Hunt syndrome, with the exception of nausea and vomiting. These symptoms are probably due to the intense periorbital pain; they promptly resolve with cessation of pain.

Natural history

  • unpredictable course.
  • Acute at onset, the patient's symptoms typically last from days to weeks. B
  • Recurrences are common, taking place in about a half of reported patients, usually at an interval of months or years from the initial attack.
    • These recurrences may be ipsilateral, contralateral, or rarely, bilateral.
  • A self limited illness, it does cause considerable morbidity. Infrequently, residual cranial nerve palsies persist. With the institution of corticosteroid therapy, the natural course is altered.

Pathology

  • An idiopathic inflammatory process.
    • Granulomatous inflammation, with epithelioid cells and occasional giant cells.
    • Necrosis may also be seen.
    • Not associated with infectious organism
    • of the cavernous sinus and orbital apex, with thickening of the sinus dura mater.

Mechanism

  • Unknown cause
    • No information is available as to what triggers the inflammatory process
  • Inflammation of the
    • Superior orbital fissure
    • Cavernous sinus.

Imaging

  • MRI findings (may show evidence of inflammatory changes in the anterior cavernous sinus, superior orbital fissure and orbital apex):
    • T1: Iso to hypo intense.
    • T2: Hyperintense (hypointense if fibrous tissue substitution).
    • Postcontrast T1: Asymmetrical enhancement.
    • Narrowing of the cavernous ICA may be present.
  • Specific case findings (as depicted in the images):
      • Postcontrast axial T1 + 6 (A) and coronal T1 (B) T2 (A) show an asymmetrical enhancing enlargement of the left cavernous sinus (red circle).
      • There is reduced T2 signal due to fibrous tissue proliferation (C, red arrow).
      • The left ICA was occluded, which is noted by the flow void loss in the coronal sequences (B, C, yellow arrows).
      • Confirmed occlusion on 3D TOF-MRA (D).
      notion image

Treatment

  • Steroids
    • Although there is no conclusive evidence to show that steroids lessen the degree or duration of the ophthalmoplegia, there is dramatic reduction of pain, often within 24 hours.